-
Endo Pharmaceuticals Inc. v. Sun Pharmaceutical Industries, Ltd. et al DC CAFC
- 1:13-cv-08597
- S.D.N.Y.
- Judge: Thomas P. Griesa
- Filed: 12/03/2013
- Closed: 06/29/2016
- Latest Docket Entry: 10/26/2022
- PACER
- Docket updated daily
1
Plaintiff
4
Defendants
1
Accused
Product
3
Patents-in-Suit
940
Days in
Litigation
-
Endo Pharmaceuticals Inc. v. Sun Pharmaceutical Industries, Ltd. et al DC CAFC
- 1:13-cv-08597
- S.D.N.Y.
- Judge: Thomas P. Griesa
- Filed: 12/03/2013
- Closed: 06/29/2016
- Latest Docket Entry: 10/26/2022
- PACER
- Docket updated daily
Market Sector
Biotech and Pharma
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
-
Infringement
Ranbaxy Incorporated
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic version of OPANA ER | US 8,309,122 B2 | All Asserted Claims |
Infringement
Entry 132
|
| generic version of OPANA ER | US 8,329,216 B2 | All Asserted Claims |
Infringement
Entry 132
|
Ranbaxy Pharmaceuticals Incorporated
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic version of OPANA ER | US 8,309,122 B2 | All Asserted Claims |
Infringement
Entry 132
|
| generic version of OPANA ER | US 8,329,216 B2 | All Asserted Claims |
Infringement
Entry 132
|
Sun Pharmaceutical Industries Limited
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic Oxymorphone ER Tabletsgeneric version of OPANA ER | US 8,309,122 B2 | All Asserted Claims |
Infringement
Entry 132Entry 97 Entry 96 |
| Generic Oxymorphone ER Tabletsgeneric version of OPANA ER | US 8,329,216 B2 | All Asserted Claims |
Infringement
Entry 132Entry 97 Entry 96 |
